The term “DIDMOAD” syndrome – an acronym for the characteristic symptoms – serves as an alternative name for this autosomal recessive neurodegenerative disease, which was first described in 1938: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness/Deafness. In the majority of patients, mutations in the WFS1 gene can be detected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- Journal Club
Management of axial spondyloarthritis
- Multiple myeloma
DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy
- COPD
Better outcomes through patient education and integrated care
- Interview
“Wearables are increasingly accepted as an aid”
- Exogenous allergic alveolitis
Recommendations for therapy for the first time
- Kidney cancer
Urine test could halve the number of postoperative kidney cancer scans
- Evidence, potential and limits